Utilizing the CHA₂DS₂-VASc-HSF Score to Predict Subclinical Acute Kidney Injury from Contrast Agents: A Focus on Neutrophil Gelatinase-Associated Lipocalin Biomarker
SCI-AKI and CHA₂DS₂-VASc-HSF Score
DOI:
https://doi.org/10.56260/sciena.v4i6.287Keywords:
Acute kidney injury, Neutrophil Gelatinase-Associated Lipocalin, Percutaneous coronary intervention, SCI-AKIAbstract
Background: Contrast-Induced Acute Kidney Injury (CI-AKI) is a common complication in patients undergoing Percutaneous Coronary Intervention (PCI), with Subclinical Contrast-Induced Acute Kidney Injury (SCI-AKI) detectable via biomarkers like Neutrophil Gelatinase-Associated Lipocalin (NGAL). The CHA₂DS₂-VASc score, developed for stroke risk in atrial fibrillation, has been modified to CHA₂DS₂-VASc-HSF for assessing cardiovascular risk, but its role in predicting SCI-AKI remains unclear. Objectives: This study aimed to evaluate the CHA₂DS₂-VASc-HSF score as an indicator for SCI-AKI risk in PCI patients, using NGAL as a biomarker for early kidney injury. Methods: A cohort study was conducted at Dr. M. Djamil General Hospital, Padang, from May to December 2024. Thirty-four patients with stable and unstable angina undergoing PCI were included. NGAL levels were measured before and after PCI. Statistical analysis examined the relationship between CHA₂DS₂-VASc-HSF score and SCI-AKI. Results: Nine patients (26.5%) were diagnosed with SCI-AKI. NGAL levels showed a significant difference between SCI-AKI positive and negative groups (p < 0.05), but no significant association was found between CHA₂DS₂-VASc-HSF score and SCI-AKI (p > 0.05). Discussion: The CHA₂DS₂-VASc-HSF score is effective for cardiovascular risk assessment but not for SCI-AKI prediction. SCI-AKI was better predicted by NGAL, a sensitive biomarker of early kidney injury. This study highlights the importance of combining multiple risk factors for accurate SCI-AKI risk stratification in PCI patients. Conclusion: The CHA₂DS₂-VASc-HSF score is not a reliable predictor for SCI-AKI. NGAL remains a valuable biomarker for early detection, emphasizing the need for a multifactorial approach in managing renal complications post-PCI.
References
. Abd-AlKhaleq A, Hamoda MA, Abd al-naby MS, Khalil MM. Comparison of Novel Risk Score CHA2DS2-VASc-HSF to CHADS2and CHA2DS2-VASc Scores to Predict the Risk of Severe Coronary Artery Disease. Benha Medical Journal. 2024:-.
. Al-Maimoony T, Al-Sageer N, Alnajjar M, Ali Kaid MG, Rajeh M, Al-Motarreb AL. Clinical Characteristics and Outcome of Percutaneous Coronary Intervention in Yemeni Patients. Heart Views [Internet]. 2023;24(2):93–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/37305329
. Al-Shorbagy AN, Al-Cekelly MM, Dwedar AA-S, Soliman MH. The Predictive Value Of Newly Defined Cha2ds2-Vasc-Hsf Score For Severity Of Coronary Artery Disease In Non St Segment Elevation Myocardial Infarction. Zagazig University Medical Journal. 2018;24(4):289-96.
. Andreucci, M., et al. "Prevention of Contrast-Induced Nephropathy: A Review." European Review for Medical and Pharmacological Sciences.
. Andreucci, M., et al. "Prevention of Contrast-Induced Nephropathy: A Review." European Review for Medical and Pharmacological Sciences
. Andreucci, M., Solomon, R., Tasanarong, A. "Side Effects of Radiographic Contrast Media: Pathogenesis, Risk Factors, and Prevention." BioMed Research International.
. Balemans, C. E., et al. "A New Risk Score for the Prediction of Contrast-Induced Nephropathy in Patients Undergoing Primary Percutaneous Coronary Intervention." American Heart Journal
. Basile DP, Anderson MD, Sutton TA. Pathophysiology of acute kidney injury. Compr Physiol [Internet]. 2012 Apr;2(2):1303–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23798302
. Cicek G, Yıldırım E. CHA2DS2-VASc score predicts contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction, who have undergone primary percutaneous coronary intervention. Kardiol Pol (Polish Hear Journal) [Internet]. 2018;76(1):91–8. Available from: https://journals.viamedica.pl/kardiologia_polska/article/view/KP.a2017.0177
. Filiopoulos V, Biblaki D, Lazarou D, Chrisis D, Fatourou M, Lafoyianni S, et al. Plasma neutrophil gelatinase-associated lipocalin (NGAL) as an early predictive marker of contrast-induced nephropathy in hospitalized patients undergoing computed tomography. Clin Kidney J. 2013 Dec;6(6):578–83.
. Fokkema ML, James SK, Albertsson P, Aasa M, Åkerblom A, Calais F, et al. Outcome after percutaneous coronary intervention for different indications: long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). EuroIntervention [Internet]. 2016 Jun;12(3):303–11. Available from: http://www.pcronline.com/eurointervention/100th_issue/50
. Huynh TAK, Nguyen TN, Nguyen PN. Study of the Correlation Between CHA2DS2- VASc-HSF Score and the Number of Injured Coronary Artery Branches in Patients With Non-St-Elevation Acute Myocardial Infarction at Can Tho Central General Hospital. Tạp Chí Y Dược Học Cần Thơ. 2022(47):53-
. Kafkas, N., Demponeras, C., Zoubouloglou, F., Spanou, L., Babalis, D., & Makris, K. (2012). Serum levels of gelatinase associated lipocalin as indicator of the inflammatory status in coronary artery disease. International journal of inflammation, 2012.
. Lameire, N., et al. "Contrast-Induced Acute Kidney Injury: An Update." Nature Reviews Nephrology.
. McIlroy, D. R., Farkas, D., Matto, M., & Lee, H. T. (2015). Neutrophil gelatinase– associated lipocalin combined with delta serum creatinine provides early risk stratification for adverse outcomes after cardiac surgery: a prospective observational study. Critical care medicine, 43(5), 1043.
. Mehran, R., et al. "Contrast-Induced Nephropathy: Definition, Epidemiology, and Implications." The Lancet.
. Nephropathy (AMACING): A Randomised, Controlled, Open-Label, Non-Inferiority Trial." The Lancet.
. Nijssen, E. C., et al. "Prophylactic Intravenous Hydration to Protect Renal Function from Intravascular Iodinated Contrast Material in Patients at High Risk of Contrast-Induced
. Nijssen, E. C., et al. "Prophylactic Intravenous Hydration to Protect Renal Function from Intravascular Iodinated Contrast Material in Patients at High Risk of Contrast-Induced Nephropathy (AMACING): A Randomised, Controlled, Open-Label, Non-Inferiority Trial." The Lancet.
. Panduranga P, Al-Rashidi M, Al-Hajri F. n-Hospital and One-Year Clinical Outcome of Percutaneous Coronary Intervention in a Tertiary Hospital in Oman: Oman PCI Registry. Oman Med J [Internet]. 2017 Jan 4;32(1):54–61. Available from: http://omjournal.org/articleDetails.aspx?coType=1&aId=1859
. Petrova I, Alexandrov A, Vladimirov G, Mateev H, Bogov I, Paskaleva I, Gotcheva N. NGAL as Biomarker of Clinical and Subclinical Damage of Kidney Function after Coronary Angiography. Diagnostics. 2023;13(1180):1-19. Available from: https://doi.org/10.3390/diagnostics13061180
. Solomon, R., et al. "Contrast Media and Nephropathy: Findings from Systematic Reviews and Meta-Analyses." American Journal of Medicine.
. Uysal OK, Turkoglu C, Duran M, Kaya MG, Sahin DY, Gur M, Cayli M. Predictive value of newly defined CHA2DS2-VASc-HSF score for severity of coronary artery disease in ST segment elevation myocardial infarction. Kardiol Pol. 2016;74(9):954-60. doi: 10.5603/KP.a2016.0054. Epub 2016 Apr 26. PMID: 27112941.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Masrul Syafri, Alles Firmansyah, Merlin Sari Mutma Indah, Yui Muya
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
